The glycoprotein CD147 defines miRNA‐enriched extracellular vesicles that derive from cancer cells by Song Yi Ko, WonJae Lee, Melanie Weigert, Eric Jonasch, Ernst Lengyel, Honami Naora

Get full text

Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States by Eric Jonasch, Yan Song, Jonathan Freimark, Richard Berman, Ha Nguyen, James Signorovitch, Murali Sundaram

Get full text

Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials by Pavlos Msaouel, Nizar M. Tannir, Eric Jonasch, Hung Le, Andrew W Hahn, Omar Alhalabi, Erick Campbell

Get full text

Understanding the Impact of Belzutifan on Treatment Strategies for Patients with VHL by Aileen Arevalo, Neal Patel, Peter Muraki, Shinji Ohtake, Gennady Bratslavsky, Chandra Clark, Joshua Mann, Othon Iliopoulos, Eric Jonasch, Ramaprasad Srinivasan, Brian Shuch

Get full text

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening by Guangchun Han, Wei Zhao, Xiaofeng Song, Patrick Kwok-Shing Ng, Jose A. Karam, Eric Jonasch, Gordon B. Mills, Zhongming Zhao, Zhiyong Ding, Peilin Jia

Get full text

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions by Cecilia Mathó, María Celia Fernández, Jenner Bonanata, Xian-De Liu, Ayelen Martin, Ana Vieites, Gabriela Sansó, Marta Barontini, Eric Jonasch, E. Laura Coitiño, Patricia Alejandra Pennisi

Get full text

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma by Cristiane Decat Bergerot, Dena Battle, Paulo Gustavo Bergerot, Nazli Dizman, Eric Jonasch, Hans J. Hammers, Daniel J. George, Axel Bex, Borje Ljungberg, Sumanta Kumar Pal, Michael D. Staehler

Get full text

Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma by Thomas Powles, Toni K. Choueiri, Robert J. Motzer, Eric Jonasch, Sumanta Pal, Nizar M. Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T. Aftab, Bernard Escudier, Daniel J. George

Get full text

Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma by Thomas Powles, Toni K. Choueiri, Robert J. Motzer, Eric Jonasch, Sumanta Pal, Nizar M. Tannir, Sabina Signoretti, Rajesh Kaldate, Christian Scheffold, Evelyn Wang, Dana T. Aftab, Bernard Escudier, Daniel J. George

Get full text

Cadherin-11 in renal cell carcinoma bone metastasis. by Robert L Satcher, Tianhong Pan, Chien-Jui Cheng, Yu-Chen Lee, Song-Chang Lin, Guoyu Yu, Xiaoxia Li, Anh G Hoang, Pheroze Tamboli, Eric Jonasch, Gary E Gallick, Sue-Hwa Lin

Get full text

523 Nivolumab and ipilimumab in patients with metastatic non-clear cell renal cell carcinoma at MD Anderson Cancer Center by Jianjun Gao, Pavlos Msaouel, Nizar Tannir, Eric Jonasch, Matthew Campbell, Amishi Shah, Priya Rao, Omar Alhalabi, Sangeeta Goswami, Nathaniel Wilson, Elshad Hasanov, Jaanki Khandelwal, Devaki S Surasi, Sergio P Klimkowsky, Mohammad J Moussa, Andrew Hahn, Kanishka Sircar

Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. by Lorenzo Cohen, Steven W Cole, Anil K Sood, Sarah Prinsloo, Clemens Kirschbaum, Jesusa M G Arevalo, Nicholas B Jennings, Shellie Scott, Luis Vence, Qi Wei, Diane Kentor, Laszlo Radvanyi, Nizar Tannir, Eric Jonasch, Pheroze Tamboli, Louis Pisters

Get full text

Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma by Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah

Get full text

AKT isoform-specific expression and activation across cancer lineages by Jue Wang, Wei Zhao, Huifang Guo, Yong Fang, Sarah Elizabeth Stockman, Shanshan Bai, Patrick Kwok-Shing Ng, Yang Li, Qinghua Yu, Yiling Lu, Kang Jin Jeong, Xiaohua Chen, Meng Gao, Jiyong Liang, Wentao Li, Xingsong Tian, Eric Jonasch, Gordon B. Mills, Zhiyong Ding

Get full text

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation by Tianhong Pan, Song-Chang Lin, Kai-Jie Yu, Guoyu Yu, Jian H. Song, Valerae O. Lewis, Justin E. Bird, Bryan Moon, Patrick P. Lin, Nizar M. Tannir, Eric Jonasch, Christopher G Wood, Gary E. Gallick, Li-Yuan Yu-Lee, Sue-Hwa Lin, Robert L. Satcher

Get full text

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma by Xian-De Liu, Wen Kong, Christine B. Peterson, Daniel J. McGrail, Anh Hoang, Xuesong Zhang, Truong Lam, Patrick G. Pilie, Haifeng Zhu, Kathryn E. Beckermann, Scott M. Haake, Sevinj Isgandrova, Margarita Martinez-Moczygemba, Nidhi Sahni, Nizar M. Tannir, Shiaw-Yih Lin, W. Kimryn Rathmell, Eric Jonasch

Get full text

718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies by Li Zhang, Ning Li, Brendan Curti, Stephen Spurgeon, Elisabeth Heath, Naomi Hunder, Eric Jonasch, Dingwei Ye, Zhu Chen, Melissa Reimers, Stephen Park, Weidong Li, Paolo Caimi, Ulka N Vaishampayan, Benjamin Garmezy, Swetha Kambhampati, Catherine Diefenbach, Noah Kornblum, Weili Zhao, Sharon Ma, Eric Song, Justin A Call

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events by Jennifer Wang, Jianjun Gao, Pavlos Msaouel, Padmanee Sharma, Nizar Tannir, Sumit K Subudhi, Eric Jonasch, Amishi Shah, Matthew T Campbell, Bilal A Siddiqui, Jinesh S Gheeya, Rohit Goswamy, Tharakeswara K Bathala, Devaki Shilpa Surasi, Sangeeta Goswami, Amado J Zurita, Paul G Corn, Ana M Aparicio, Arlene O Siefker-Radtke

Get full text

Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical out... by Andrew L. Laccetti, Benjamin Garmezy, Lianchun Xiao, Minas Economides, Aradhana Venkatesan, Jianjun Gao, Eric Jonasch, Paul Corn, Amado Zurita‐Saavedra, Landon C. Brown, Chester Kao, Emily N. Kinsey, Rajan T. Gupta, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, Nizar Tannir, Pavlos Msaouel, Amishi Shah, Tian Zhang, Matthew T. Campbell

Get full text

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) by Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins

Get full text